Updated June 15
Who Actually Writes Those GLP-1 Rankings? Mostly the Programs Being Ranked.
Most “best GLP-1 program” lists share one problem nobody writing those lists wants to say out loud: the list was written by someone with a financial stake in the outcome. Here is how that works, what it means for patients choosing a program, and the four questions any independent list should be able to answer.
Search “best GLP-1 program” and you get a dozen ranked lists. Most of them have the same problem, and nobody writing those lists wants to say it out loud. The list was written by someone with a financial stake in the outcome. This is not a conspiracy. It is just how the category works right now, and patients deserve to know it before they pick a program.
- Three structural types of biased ranking and how each one works without being illegal.
- What the bias actually costs patients when the ranked order flips at the maintenance dose.
- Four questions an independent list must answer. If it cannot answer all four, it is marketing.
- How GLP Chart is structured differently and why that structure is the only design decision that makes independent comparison possible.
The three types of list you are reading
Type 1: The program ranked itself.
Some of the programs you are comparing publish their own “best of” lists. The list names their competitors. Their own program appears at the top. No competing program wrote the list, and no competing program approved the methodology. This happens openly, without disclosure, on multiple telehealth programs' blogs today. The list ranks as editorial content in search engines because it follows editorial formatting, but it was written to convert traffic into paying members.
You would not trust a car dealer's ranking of the top five cars in the category if their car were on it. This is that.
Type 2: The publisher earns commissions in the order programs appear.
Some publishers (health media outlets, digital magazines, general telehealth comparison sites) publish GLP-1 program rankings monetized through affiliate commissions. Programs pay the publisher a fee when a reader clicks through and enrolls. In those arrangements, the programs at the top of the list are not always the cheapest or highest-scored. Sometimes they earn the publisher the highest commission.
The FTC requires affiliate disclosure, and many publishers include it. But “this post may contain affiliate links” does not tell you that the ranking order itself is influenced by which program pays more per conversion. There is a difference between disclosing that you earn a commission and disclosing that the commission rate affected where a program appears in the list.
Type 3: The publisher cannot say anything negative about programs it covers.
Ad-funded health publishers earn revenue from the programs and drug categories they cover. A publisher that earns advertising dollars from a GLP-1 telehealth program is not going to publish a head-to-head that says that program's pricing is worse than its competitor's at the titration dose. The ranking stays positive because the monetization relationship requires it to stay positive. No individual person makes that decision. The incentive structure makes it automatic.
What this means for patients
None of the above is illegal. Some of it is disclosed. But it produces a practical problem: the comparison list that shows up on page one of search results was often written by someone who cannot be fully neutral.
When you use a list like that to pick a program, you are not comparing programs. You are looking at a marketing funnel with comparison-table formatting applied on top.
The effect is real. Programs vary in ways that matter: headline price versus what you pay at the maintenance dose, whether the platform fee is bundled or extra, whether the prescriber can adjust the dose or requires a new visit, whether the program covers branded or compounded or both. A list that ranked programs in neutral order and then explained those distinctions would often produce a different result than the ranked lists currently on the first page of search.
The standard independent rankings should meet
An independent GLP-1 comparison should be able to answer four questions:
- Did anyone pay to be included, or to rank higher? If yes, say which programs, how much, and how that payment affected their position.
- How often are prices verified? GLP-1 program pricing changes. A list that does not say when prices were checked last is working from stale data.
- What is the all-in price at the maintenance dose, not the intro price? Many programs advertise the first-month price. The ongoing monthly cost at the dose most patients stabilize at is a different number.
- Does the publisher run a competing service? If the site ranking GLP-1 programs also sells GLP-1 prescriptions, it cannot rank all programs with equal neutrality.
If you cannot find clear answers to all four, the list is not a comparison. It is marketing.
Why GLP Chart is different (and why we say so)
GLP Chart publishes a weekly price index for GLP-1 programs. The scores are set before any affiliate link is assigned. No program pays for placement. No program pays for ranking. A program's score does not change if it starts or stops an affiliate arrangement with us.
We earn commissions when a reader visits a program through our site and enrolls. That model is standard in this category and it is disclosed: “Some visit links earn us a commission.” But the score that determines where a program appears is set on criteria the program cannot influence by paying us: cash-pay price at the maintenance dose, price transparency, what is included in the fee, and whether compounded or branded supply is offered.
We also verify prices every Monday. If a program raises its price between our Monday checks, our next update will show it. The programs are not consulted before prices go in.
The methodology is published at glpchart.com/methodology/. Anyone can read how scores are calculated and weighted before clicking a single link.
We built it this way because the conflict described above is the only structural problem the comparison category has. If you know a program's price and score before the affiliate relationship is assigned, no commission payment can change the answer. That is the one design decision that makes independent comparison possible.
A note on the sites that claim independence
Several newer GLP-1 comparison sites have appeared in 2025 and 2026. Some claim they do not take payments from programs for placement or ranking. That claim is worth taking seriously, and worth verifying.
The way to verify it: look for a published methodology that describes when prices were checked, what data sources were used, and how the ranking criteria were weighted. A claim of independence supported by a documented methodology is credible. A claim of independence with no supporting methodology is still just a claim.
We are not exempt from that standard. The methodology page is there to hold us to it.
Where to go from here
If you want a comparison that shows you where the money flows: the GLP Chart homepage lists every US program, scored before any affiliate relationship is assigned, with prices checked every Monday.
The best-for shortlists rank programs by specific situation (cash pay, insurance, compounded, no lock-in, fast onboarding) using the same neutral scoring. They are the independent rankings this editorial is about.
If you find an error in our data or our methodology, the contact is on the site. We correct it.
GLP Chart is an independent GLP-1 price comparison and education site. Some visit links earn us a commission. No program pays to be included or to rank higher. Prices verified every Monday. Methodology: glpchart.com/methodology/.
Frequently asked questions
Are GLP-1 program rankings biased?
Many of them are, structurally. Some are written by programs that rank themselves at the top. Others are ordered by which program pays the publisher the highest affiliate commission per enrollment. A third type avoids negative coverage because the publisher earns ad revenue from the programs it covers. None of this is illegal, and some of it is disclosed, but it means the list a patient finds on page one of search was often written by someone who cannot be fully neutral.
How can I tell if a GLP-1 ranking is independent?
Ask four questions. First: did anyone pay to be included, or to rank higher? If yes, the methodology should say which programs, how much, and how that payment affected their position. Second: when were prices last checked? GLP-1 pricing changes, and a list with no verification date is working from stale data. Third: does the list show the all-in price at the maintenance dose, not just the intro price? Many programs advertise the first-month price; the ongoing monthly cost at the dose most patients stabilize at is a different number. Fourth: does the publisher run a competing service? A site that also sells GLP-1 prescriptions cannot rank all programs with equal neutrality. If you cannot find clear answers to all four, the list is not a comparison. It is marketing.
What does GLP Chart do differently from other GLP-1 ranking sites?
GLP Chart scores programs before any affiliate link is assigned. No program pays for placement or ranking. A program's score does not change if it starts or stops an affiliate arrangement. Prices are checked every Monday against each program's own published pricing page. The scoring methodology is published at glpchart.com/methodology/ so anyone can read how scores are calculated before clicking a single link.
Does GLP Chart earn commissions from GLP-1 programs?
Yes. GLP Chart earns a commission when a reader visits a program through the site and enrolls. That model is standard in this category and is disclosed: some visit links earn a commission. The distinction is that the score determining where a program appears is set on criteria the program cannot influence by paying: cash-pay price at the maintenance dose, price transparency, what is included in the fee, and whether compounded or branded supply is offered. The score is set before any affiliate relationship is assigned.
Why does the ranking order on a comparison site matter?
Because programs vary in ways that matter: headline price versus what you pay at the maintenance dose, whether the platform fee is bundled or extra, whether the prescriber can adjust the dose or requires a new visit, whether the program covers branded or compounded or both. A list that ranked programs in neutral order and then explained those distinctions would often produce a different result than the ranked lists currently on the first page of search. The ranking order is the product.
See the best GLP-1 programs by situation →
